Paclitaxel-Hyaluronic Acid for Intravesical Therapy of Bacillus Calmette-Guérin Refractory Carcinoma In Situ of the Bladder: Results of a Phase I Study-Reference-Cited by-同舟云学术

Paclitaxel-Hyaluronic Acid for Intravesical Therapy of Bacillus Calmette-Guérin Refractory Carcinoma In Situ of the Bladder: Results of a Phase I Study

Published:2011-02 Issue:2 Volume:185 Page:445-449
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Bassi P.F.¹,Volpe A.¹,D'Agostino D.¹,Palermo G.¹,Renier D.²,Franchini S.²,Rosato A.³,Racioppi M.¹

Affiliation:

1. Department of Urology, Catholic University School of Medicine, Rome, Italy

2. Fidia Farmaceutici S.p.A. – Abano Terme, Italy

3. Department of Oncology and Surgical Sciences, University of Padova, and Istituto Oncologico Veneto IRCCS, Padova, Italy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. Recent cancer trends in the United States;Devesa;J Natl Cancer Inst,1995

2. Introduction and overview of intravesical therapy for superficial bladder cancer;Soloway;Urology,1988

3. Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer;Hasui;Urology,1994

4. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group study;Lamm;J Urol,2000

5. Penetration of mitomycin C in human bladder;Wientjes;Cancer Res,1993

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A paclitaxel-hyaluronan conjugate (ONCOFID-P-B™) in patients with BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the tumor microenvironment;Journal of Experimental & Clinical Cancer Research;2024-04-10

2. Experimental and New Approaches for Bladder Preservation in Intermediate and High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC);Research and Reports in Urology;2024-04

3. Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid Instillations in Bladder Cancer;Journal of Clinical Medicine;2024-03-31

4. Versatile Component of Extracellular Matrix: Hyaluronan with Dual Application in Understanding Cancer Progression Initiation and Cancer Inhibition;Interdisciplinary Cancer Research;2024

5. p53 dry gene powder enhances anti-cancer effects of chemotherapy against malignant pleural mesothelioma;Gene Therapy;2023-10-13